These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 10959029)
1. Primary prevention of sudden cardiac death - the role of antiarrhythmic drug therapy. Touboul P Resuscitation; 2000 Aug; 45(3):S11-5. PubMed ID: 10959029 [No Abstract] [Full Text] [Related]
2. Sudden death due to cardiac arrhythmias. Huikuri HV; Castellanos A; Myerburg RJ N Engl J Med; 2001 Nov; 345(20):1473-82. PubMed ID: 11794197 [No Abstract] [Full Text] [Related]
3. [Antiarrhythmic drug therapy in patients with heart failure]. Nakamura K; Nishii N; Ohe T Nihon Rinsho; 2007 May; 65 Suppl 5():369-74. PubMed ID: 17571408 [No Abstract] [Full Text] [Related]
4. Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator. Domanski MJ J Interv Cardiol; 1995 Feb; 8(1):9-15. PubMed ID: 10155222 [No Abstract] [Full Text] [Related]
5. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. Adabag AS; Maron BJ Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):171-80. PubMed ID: 17593187 [No Abstract] [Full Text] [Related]
7. Revisiting established medical options - antiarrhythmic drugs and beta-blocker combinations. Obel OA Resuscitation; 2000 Aug; 45(3):S7-S10. PubMed ID: 10959028 [No Abstract] [Full Text] [Related]
8. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
9. [Clinical therapy for arrhythmias and EBM]. Otsuka T; Yamashita T Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):234-9. PubMed ID: 16536072 [No Abstract] [Full Text] [Related]
10. Sudden cardiac death: prevention and treatment. Kwok KM; Lee KL; Lau CP; Tse HF Hong Kong Med J; 2003 Oct; 9(5):357-62. PubMed ID: 14530531 [TBL] [Abstract][Full Text] [Related]
12. Drugs to prevent sudden cardiac death. Erath JW; Hohnloser SH Int J Cardiol; 2017 Jun; 237():22-24. PubMed ID: 28341373 [TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study]. Meinertz T; Zehender M; Hohnloser SH Z Kardiol; 1992; 81 Suppl 4():145-9. PubMed ID: 1290291 [TBL] [Abstract][Full Text] [Related]
15. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies. Siddiqui A; Kowey PR Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017 [TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic therapies for the prevention of sudden cardiac death. McAlister FA; Teo KK Drugs; 1997 Aug; 54(2):235-52. PubMed ID: 9257080 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive arrhythmia risk assessment in guiding pharmacologic therapy for prevention of sudden cardiac death: where do we stand? Where do we go? Verrier RL; Josephson ME J Cardiovasc Pharmacol; 2010 May; 55(5):425-7. PubMed ID: 20224430 [No Abstract] [Full Text] [Related]
18. Prevention of sudden cardiac death: a current perspective. Domanski MJ; Exner DV J Electrocardiol; 1998; 31 Suppl():47-53. PubMed ID: 9988005 [No Abstract] [Full Text] [Related]
20. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?]. Naccarella F; Croci F G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037 [No Abstract] [Full Text] [Related] [Next] [New Search]